CORE
đșđŠÂ
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
40 research outputs found
Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma
Author
A Moros
AA Alizadeh
+68Â more
AK Pasanen
AM Ranger
AR Hussain
AR Hussain
B Kloo
C Zang
CJ Sherr
CY Ok
D Chauhan
D Chiron
D Chiron
D Joyce
DF James
DL Vaux
DP Calado
F Jardin
F Turturro
FJ Hernandez-Ilizaliturri
G Lenz
GS Nowakowski
GS Nowakowski
J Wong
JD Peyton
JF Fecteau
JS Lee
Junmin Li
K Weber
Kai Qing
L Odqvist
L Rosich
L Zhang
L-H Zhang
LA Mathews Griner
LH Sehn
M Barkett
M Compagno
M Ehinger
M Karin
M Keimpema van
M Rahmani
N Chen
N Sandhofer
O Al-Assar
P Bavi
P Feugier
PM Bhende
Q Zhao
R Lapalombella
R Seki
R Siegel
SC Hsiao
SE Herman
SE Trabucco
SS Han
SS Wenzel
T Ahmadi
T Vela-Chavez
VN Ngo
Wenfang Wang
Xiaoyang Li
Y Qu
Y Yang
Yuan Ouyang
Z Qian
Zhao Liu
Zhen Jin
Zizhen Xu
ZY Gan
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Author
A Chanan-Khan
A Lopez-Girona
+95Â more
AA Hyder
AE Cardona
AG Mustafa
AL Moreira
Barry J. Hoffer
BG Lyeth
C Mahony
C Werner
C Zhang
CE Dixon
CG Gourin
Chaim G. Pick
Chong-Chi Chiu
CV Borlongan
CX Wang
D Tweedie
David Tweedie
DE Barnes
DM Feeney
E Shohami
E Shohami
EM Ocio
EN Benveniste
EP Sampaio
F Tagliaferri
FE Davies
FJ Hernandez-Ilizaliturri
G Barkhoudarian
GL Clifton
HY Shi
IK Moppett
J Kling
J Sheskin
J Shortt
JA Langlois
Jia-Yi Wang
Jing-Ya Wang
JS Yoon
K Eger
KA Frankola
KM Lee
L Calabrese
L Longhi
L Marchetti
LC Schmued
LC Schmued
LY Yang
M Aizawa
MC LaPlaca
MC Morganti-Kossmann
MK McCoy
ML Prins
MS Choudhery
MW Greve
N Plesnila
N Vargesson
NH Greig
Nigel H. Greig
O Zohar
OI Schmidt
PG Sullivan
PJ Bergold
R Baratz
R Baratz
RC Gardner
RJ Hamm
RL Ruff
RL Smith
S Jo
S Niwayama
S Shalapour
S Teo
S WeingÀrtner
SA Ross
SF Chen
SF Chen
SM Knoblach
SP Gabbita
SW Barger
Szu-Yi Chou
T Frugier
T Ito
U Scherbel
V Bouet
W Schneider-Brachert
Weiming Luo
WM Liu
WT Chiu
XB Chang
Ya-Ni Huang
YN Huang
Yu Luo
YX Zhu
Z Hanaizi
Z Li
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies
Author
Anne Evesque
Béatrice Clémenceau
+6Â more
Charles Dumontet
Doriane Mathé
Eva-Laure Matera
Hernandez-Ilizaliturri FJ
Minh Ngoc Duong
Sandrine Valsesia-Wittmann
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer
Author
Andrew J Madden
Bruce Oberhardt
+14Â more
C Ryan Miller
Charlene Santos
David Arney
Dustin Lockney
Hernandez-Ilizaliturri FJ
Lawrie TA
Matsumura Y
Paola Gehrig
Peng L
Preethi Vennam
Rai H
Stefan Franzen
Steven A Lommel
William C Zamboni
Publication venue
'Future Medicine Ltd'
Publication date
Field of study
No full text
Crossref
Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial
Author
Buske C
Hernandez-Ilizaliturri FJ
+20Â more
Hiddemann W
Kengo Takeuchi
Kensei Tobinai
Kiyoshi Ando
Kunihiro Tsukasaki
Masafumi Taniwaki
Michinori Ogura
Motoko Yamaguchi
Naokuni Uike
Nobuo Maseki
Rummel MJ
Shigeru Nawano
Takashi Terauchi
Takashi Watanabe
Takayo Suzuki
Taro Shibata
Tomohiro Kinoshita
Tomomitsu Hotta
Yasuo Morishima
Young RC
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse
Author
AgnÚs Quéméner
Anne Bessard
+20Â more
Boross P
Béatrice Clémenceau
David BĂ©chard
Davis TA
Gilles Thibault
Gillies SD
Gillies SD
Giri JG
GĂ©raldine Teppaz
Hernandez-Ilizaliturri FJ
Hori T
Laure Garrigue-Antar
Laurie Lajoie
Marie Vincent
McLaughlin P
Mike Maillasson
Perdreau H
SĂ©verine Loisel
Véronique Solé
Yannick Jacques
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
The Role of Complement in the Mechanism of Action of Rituximab for BâCell Lymphoma: Implications for Therapy
Author
Chan HT
Deans JP
+21Â more
Golay J
Golay J
HernandezâIlizaliturri FJ
Hong F
Inoue H
Kurtz CB
Li B
Maloney DG
Nagamune H
Ollert MW
Paganelli G
Papadimitriou JC
Paul MS
Reiter Y
Shin ML
Smith MR
Telen MJ
Weiguo Hu
Xia Y
Xuebin Qin
Xuhui Zhou
Publication venue
'Alphamed Press'
Publication date
Field of study
No full text
Crossref
1
2
3
4